Concepedia

Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease

Ryan C. Ungaro, Clara Yzet, Peter Bossuyt, Filip J. Baert, Thomas Vanasek, Geert D’Haens, V Joustra, Remo Panaccione, Gottfried Novacek, Walter Reinisch,

Gastroenterology · 2020 · 238 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 912 citations

, , +3

Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

Johan Burisch, Gediminas Kiudelis, Limas Kupčinskas et al. · Gut · 2018 · 290 citations · Full text

, , +13

Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease

Thomas D. Walters, Mi‐Ok Kim, Lee A. Denson et al. · Gastroenterology · 2013 · 267 citations · Full text

, , +14

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

Stefan Schreiber, Jean‐Frédéric Colombel, Ralph Bloomfield et al. · The American Journal of Gastroenterology · 2010 · 231 citations

, , +17

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a <scp>SONIC </scp><i>post hoc</i> analysis

Jean‐Frédéric Colombel, Walter Reinisch, Gerassimos J. Mantzaris et al. · Alimentary Pharmacology & Therapeutics · 2015 · 192 citations · Full text

, , +17